Cambridge Healthtech Training Seminars offer real-life case studies, problems encountered and solutions applied, and extensive coverage of the basic science underlying each topic. Experienced Training Seminar instructors offer a mix of formal lectures, interactive discussions and activities to help attendees maximize their learning experiences. These immersive trainings will be of value to scientists from industry and academic research groups who are entering new fields – and to those working in supporting roles that will benefit from an in-depth briefing on a specific aspect of the industry.
TS1: Immunology for Biotherapeutics
Understanding and Exploiting the Immune System
October 24-25, 2017
This 1.5-day lecture-based seminar led by experts in their fields will examine the roles of the various cells involved in the immune response and how they can be manipulated and harnessed for therapeutic purposes. Attendees will learn about the importance of T cells, how they are activated, and their role in immune regulation. The course will include immunotherapy particularly for oncology, such as the exciting advances in controlling checkpoint inhibitors, and application of adoptive T cell therapy such as CAR-Ts. Safety aspects of manipulating the immune response will be emphasized and examples of what can go wrong will be provided. Current developments with vaccines will be covered and we will examine the impact of immunogenicity on safety and efficacy of biotherapeutics.
Who should attend: Scientists and academics in all aspects of drug discovery and development, including biotherapeutic engineering, drug development, analytical sciences, bioproduction, and preclinical, translational and clinical studies, oncology and gene therapy.
View Detailed Agenda
Ethan Shevach, M.D., Senior Investigator, Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, NIH
David H. Margulies, M.D., Ph.D., Chief, Molecular Biology, Laboratory of Immunology Lab, NIAID, National Institutes of Health
Paul Moore, Vice President, Immunology and Cell Biology, Macrogenics, Inc.
Rakesh Dixit, Ph.D., Vice President, R&D, Global Head, Biologics Safety Assessment, MedImmune, Inc.
Bonita (Bonnie) Rup, Ph.D., Biopharmaceutical Consultant, Bonnie Rup Consulting
Michael Lacy, Ph.D., Lead Scientist, Non-Clinical Development, Emergent BioSolutions
Jochem Gokemeijer, Ph.D., Associate Director, Molecular Discovery Technology, Bristol-Myers Squibb
J. Joseph (Jos) Melenhorst, Ph.D., Director, Product Development & Correlative Sciences, Center for Cellular Immunotherapies, University of Pennsylvania
TS2: Introduction to Design of Experiment (DoE)
October 24-25, 2017
This 1.5-day lecture-based seminar is an introduction course to the
concept of Design of Experiments (DoE). First, trainees will learn,
using a simple example, the value of DoE and how it can drastically
increase the amount of information provided by each experiment.
Then, we’ll discuss how to choose the appropriate design for different
situations. Trainees will have an overview of the DoE catalog,
including the advantage of each type of design (Screening designs,
Factorial designs, Response-surface designs, Optimal designs).
Finally, attendees will gain an appreciation for the many ways output
can be used to better understand and optimize processes.
View Detailed Agenda
Perceval Sondag, Principal Statistician, Non-Clinical Statistics, Arlenda
Training Seminar Information:
Each CHI Training Seminar offers 1.5 days of instruction with start and stop times for each day shown above and on the Event-at-a-Glance published in the onsite Program & Event Guide. Training Seminars will include morning and afternoon refreshment breaks, as applicable, and lunch will be provided to all registered attendees on the full day of the class.
Each person registered specifically for the training seminar will be provided with a hard copy handbook for the seminar in which they are registered. A limited number of additional handbooks will be available for other delegates who wish to attend the seminar, but after these have been distributed, no additional books will be available.
Though CHI encourages track hopping between conference programs, we ask that Training Seminars not be disturbed once they have begun. In the interest of maintaining the highest quality learning environment for Training Seminar attendees, and because Seminars are conducted differently than conference programming, we ask that attendees commit to attending the entire program, and not engage in track hopping, as to not disturb the hands-on style instruction being offered to the other participants.